Drug Database
Back to search

Spain· ES:70126

EKISTOL 50 mg COMPRIMIDOS

A cilostazol product containing cilostazol, registered in Spain by Lacer S.A.. The same ATC class is registered in 8 of our 19 countries.

ATC B01AC23

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedEKISTOL 50 mg COMPRIMIDOSATCB01AC23REGISTER NO.ES:70126PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cilostazolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cilostazol is registered in 8 of 19 countries.

Countries holding a registration under ATC B01AC23 (cilostazol), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 5 of them publish a price we can compare per daily dose
Search cilostazol products by name

Cilostazol · ATC B01AC23

8 / 19 countries

  • Czechiaprice
  • Germany
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cilostazol costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • Spain: $0.85 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cilostazol · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • ES Spain$0.85
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AEMPS CIMA (Spain)
Active substance
cilostazol
Manufacturer
Lacer S.A.
Country
Spain (ES)
ATC code
B01AC23
ATC class
Cilostazol
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    661616
    56
    EUR 10.49

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

490 interactions on record for cilostazol.

Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cilostazol against other medicinesHow interaction checks work

Cilostazol · interactions on record

490 records

  • 147 severe
  • 336 moderate
  • 7 minor

Most severe, free to view

  • OmeprazoleA02BC01severe
  • LansoprazoleA02BC03severe
  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cilostazol in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cilostazol products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Bulgaria · Лостразин, Тромбай
  • Czechia · Cilostazol Stada, Noclaud
  • Germany · Cilostazol Al, Cilostazol Stada
  • Estonia · Cilostad, Cilostazol Stada
  • United Kingdom (Northern Ireland) · Cilostazol
  • Greece · Cilos, Cilostazol Galenica
  • Hungary · Antaclast, Cilostazol Teva
  • Italy · Albaten, Cilostazolo Eg
  • Lithuania · Dilsatan, Sollazon
  • Latvia · Dilsatan, Sollazon
  • Malta · Cilostazol, Cilostazol Libytec
  • Poland · Cilostazol Lek-Am, Cilostop
  • Portugal · Cilostazol Ferrer
  • Romania · Dilvas, Velyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0b98cf0-90b6-4fdc-8472-b6f7d325a1c4
GET /v1/drugs/f0b98cf0-90b6-4fdc-8472-b6f7d325a1c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Diagnóstico Hospitalario",
  "estado": "{\"aut\":1223330400000}",
  "nregistro": "70126",
  "substance": "cilostazol"
}
API referenceMCP serverPlans

See everything about cilostazol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console